A study reveals a possible explanation for why checkpoint blockade inhibitors don't work well for some patients whose tumors have a high mutational burden.
Read more https://www.sciencedaily.com/releases/2023/09/230914175112.htm
A study reveals a possible explanation for why checkpoint blockade inhibitors don't work well for some patients whose tumors have a high mutational burden.
Read more https://www.sciencedaily.com/releases/2023/09/230914175112.htm